Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Inv. presentation
Appointed director
|
|
Diadexus, Inc. (DDXS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/22/2015 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Lori Rafield, Ph.D. Appointed Permanent CEO of Diadexus SOUTH SAN FRANCISCO, Calif., April 20, 2015 -- Diadexus, Inc. , a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced the appointment of Lori F. Rafield, Ph.D. as chief executive officer of the Company on a permanent basis, effective immediately. Dr. Rafield has continued to serve as chairman since 2010. She assumed the responsibility of interim executive chair in June 2014 and then was appointed interim chief executive officer in January 2015. “Lori has assembled a leadership team with deep operating experience and we are pleased she has agreed to lead this team as Diadexus' permanent chief executive officer,” said Karen Drexler, independent director of the b..." |
|
| 10/12/2010 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 11/20/2009 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 01/12/2006 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 11/19/2004 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 11/19/2004 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 11/17/2004 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 11/09/2004 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 11/09/2004 |
8-K/A
| Form 8-K/A - Current report [Amend] |
|
|